Eight biotech companies in Melbourne you should know about
Discover 8 biotech companies in Melbourne, ranging from commercial to preclinical-stage companies, advancing promising technologies. The post Eight biotech companies in Melbourne you should know about appeared first on Labiotech.eu . © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is…
Melbourne, located on the southeastern coast of Australia, is a thriving life science hub in the Asia Pacific region. The city houses numerous innovative biotech companies, with a 20% growth in 2020, despite the overall Asia Pacific market decline. Among the eight biotech companies featured in this article, Telix Pharmaceuticals is a leading name in radiopharmaceuticals, with its flagship product Illuccix used for prostate cancer diagnosis.
The company also has an extensive clinical pipeline of radiopharmaceuticals, including TLX591-Tx for urological oncology and TLX101-Tx for glioblastoma. Ena Respiratory, another Melbourne-based biotech, focuses on prophylactics for infections with its small molecule INNA-051, which activates the innate immune system to fight viral respiratory infections.
Meanwhile, Mesoblast, a cell therapy company, received FDA approval for its drug Ryoncil to treat acute graft versus host disease in children. Revascor, another cell therapy company, is developing Revascor to treat heart disease, with an FDA nod in the pipeline.
Written by urgent.news from Labiotech's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
